Chronic Kidney Disease (CKD)
54
7
8
37
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.7%
2 terminated out of 54 trials
94.9%
+8.4% vs benchmark
15%
8 trials in Phase 3/4
22%
8 of 37 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 37 completed trials
Clinical Trials (54)
Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Patient-centered Precision Medicine Lab Result Communication for Older Adults
Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease
Trazodone and the Risk of Serious Adverse Events
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
Citalopram and the Risk of Serious Adverse Events
Sertraline and the Risk of Serious Adverse Events
Pramipexole and the Risk of Serious Adverse Events
Escitalopram and the Risk of Serious Adverse Events
Tamsulosin and the Risk of Serious Adverse Events
The CPH-MBD Cohort
A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)
A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol FLEX-1-001
Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Patients
Lorazepam and the Risk of Serious Adverse Events